| Disease ID | Disease name | Reference |
|---|
| MESH:C537268 |
Formaldehyde poisoning |
PMID:23179754 |
| MESH:C564945 |
Neuropathy, Painful |
PMID:23747933 |
| MESH:D000230 |
Adenocarcinoma |
PMID:12562630 |
| MESH:D000236 |
Adenoma |
PMID:12562630 |
| MESH:D000690 |
Amyotrophic Lateral Sclerosis |
PMID:27418175; PMID:28585120 |
| MESH:D001249 |
Asthma |
PMID:11519088; PMID:12212974; PMID:17002712; PMID:17594875; PMID:23671638 |
| MESH:D001284 |
Atrophy |
PMID:16909603; PMID:17936466 |
| MESH:D001321 |
Autistic Disorder |
PMID:25051312 |
| MESH:D001724 |
Birth Weight |
PMID:24844129 |
| MESH:D001836 |
Body Weight Changes |
PMID:27339418 |
| MESH:D001943 |
Breast Neoplasms |
PMID:15986119 |
| MESH:D001986 |
Bronchial Spasm |
PMID:19827972; PMID:19835937 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
PMID:10810126; PMID:12679049; PMID:12857938; PMID:36912747 |
| MESH:D002493 |
Central Nervous System Diseases |
PMID:18333987 |
| MESH:D002869 |
Chromosome Aberrations |
PMID:20047218; PMID:20193773; PMID:21360194; PMID:23649840 |
| MESH:D003072 |
Cognition Disorders |
PMID:30395894 |
| MESH:D003231 |
Conjunctivitis |
PMID:1683282 |
| MESH:D003371 |
Cough |
PMID:1683282; PMID:27545873 |
| MESH:D003643 |
Death |
PMID:15578646; PMID:28621308 |
| MESH:D003866 |
Depressive Disorder |
PMID:14633228 |
| MESH:D003876 |
Dermatitis, Atopic |
PMID:15218738; PMID:28005965 |
| MESH:D003877 |
Dermatitis, Contact |
PMID:12161283; PMID:15842060; PMID:25724174; PMID:6221686 |
| MESH:D003967 |
Diarrhea |
PMID:1683282 |
| MESH:D004244 |
Dizziness |
PMID:1683282 |
| MESH:D004417 |
Dyspnea |
PMID:1683282 |
| MESH:D004485 |
Eczema |
PMID:18063241 |
| MESH:D004487 |
Edema |
PMID:10543429; PMID:11642317; PMID:12161283; PMID:28422384; PMID:34896366 |
| MESH:D004844 |
Epistaxis |
PMID:1683282; PMID:28081750 |
| MESH:D005076 |
Exanthema |
PMID:1683282 |
| MESH:D005119 |
Extravasation of Diagnostic and Therapeutic Materials |
PMID:19014991 |
| MESH:D005128 |
Eye Diseases |
PMID:11723723 |
| MESH:D005141 |
Eyelid Diseases |
PMID:14996049 |
| MESH:D005157 |
Facial Pain |
PMID:17157777; PMID:18164607; PMID:20664833; PMID:21138055 |
| MESH:D005221 |
Fatigue |
PMID:1683282; PMID:17408435; PMID:21294402 |
| MESH:D005350 |
Fibroma |
PMID:12562630 |
| MESH:D006261 |
Headache |
PMID:12833854; PMID:1683282 |
| MESH:D006330 |
Heart Defects, Congenital |
PMID:16227712 |
| MESH:D006332 |
Cardiomegaly |
PMID:36706861 |
| MESH:D006345 |
Heart Septal Defects, Ventricular |
PMID:36758786 |
| MESH:D006470 |
Hemorrhage |
PMID:14633228 |
| MESH:D006930 |
Hyperalgesia |
PMID:10481416; PMID:10499367; PMID:10920437; PMID:12620371; PMID:14666255; PMID:16360148; PMID:16480831; PMID:17049512; PMID:27899695; PMID:28947236; PMID:3475494; PMID:34896366 |
| MESH:D006965 |
Hyperplasia |
PMID:16036858; PMID:20884683 |
| MESH:D006967 |
Hypersensitivity |
PMID:20123097; PMID:24844129 |
| MESH:D006968 |
Hypersensitivity, Delayed |
PMID:17594875 |
| MESH:D006973 |
Hypertension |
PMID:36706861 |
| MESH:D007153 |
Immunologic Deficiency Syndromes |
PMID:27020608 |
| MESH:D007249 |
Inflammation |
PMID:12435080; PMID:15626726; PMID:16036858; PMID:19827972; PMID:19904815; PMID:20884683; PMID:28005965; PMID:28422384; PMID:29315975 |
| MESH:D007280 |
Disorders of Environmental Origin |
PMID:17938725 |
| MESH:D007414 |
Intestinal Neoplasms |
PMID:12562630 |
| MESH:D007674 |
Kidney Diseases |
PMID:14633228; PMID:16898265; PMID:18717515 |
| MESH:D007889 |
Leiomyoma |
PMID:12562630 |
| MESH:D007890 |
Leiomyosarcoma |
PMID:12562630 |
| MESH:D007951 |
Leukemia, Myeloid |
PMID:19933446; PMID:20798648 |
| MESH:D008171 |
Lung Diseases |
PMID:20658762 |
| MESH:D008175 |
Lung Neoplasms |
PMID:14600093 |
| MESH:D008679 |
Metaplasia |
PMID:16036858; PMID:17936466; PMID:18499655; PMID:20884683 |
| MESH:D009202 |
Cardiomyopathies |
PMID:36758786 |
| MESH:D009303 |
Nasopharyngeal Neoplasms |
PMID:12857938; PMID:15191929 |
| MESH:D009325 |
Nausea |
PMID:1683282 |
| MESH:D009336 |
Necrosis |
PMID:14963899; PMID:20884683 |
| MESH:D009361 |
Neoplasm Invasiveness |
PMID:30236600 |
| MESH:D009374 |
Neoplasms, Experimental |
PMID:36116563 |
| MESH:D009410 |
Nerve Degeneration |
PMID:15820619; PMID:30395894 |
| MESH:D009437 |
Neuralgia |
PMID:18492948; PMID:18544896 |
| MESH:D009669 |
Nose Neoplasms |
PMID:36912747; PMID:4038687 |
| MESH:D009783 |
Dermatitis, Occupational |
PMID:18976378 |
| MESH:D009784 |
Occupational Diseases |
PMID:11519088; PMID:17002712 |
| MESH:D009845 |
Oligospermia |
PMID:16909603; PMID:24142868 |
| MESH:D010020 |
Osteonecrosis |
PMID:17992230 |
| MESH:D010146 |
Pain |
PMID:10445233; PMID:10543429; PMID:10602329; PMID:10604944; PMID:10698354; PMID:10743905; PMID:10813554; PMID:10967476; PMID:11516431; PMID:11785926; PMID:12133575; PMID:12595749; PMID:12890519; PMID:14598202; PMID:14975683; PMID:15102535; PMID:15142344; PMID:15569406; PMID:16155371; PMID:16259764; PMID:16305795; PMID:16442764; PMID:16507304; PMID:16508151; PMID:16563475; PMID:16650579; PMID:17331332; PMID:17976270; PMID:18605234; PMID:18761334; PMID:19010737; PMID:19109946; PMID:19260335; PMID:19552055; PMID:20383154; PMID:20422007; PMID:20727387; PMID:20727678; PMID:20849525; PMID:20863828; PMID:20952482; PMID:21171362; PMID:21547684; PMID:21634377; PMID:22236721; PMID:23562495; PMID:24758774; PMID:25128769; PMID:25617481; PMID:27277137; PMID:27302204; PMID:28947236; PMID:29499192; PMID:29655911; PMID:7694222; PMID:7869613; PMID:8690236; PMID:8773445; PMID:9126180; PMID:9178196; PMID:9308027; PMID:9592021; PMID:9714424 |
| MESH:D010612 |
Pharyngitis |
PMID:1683282 |
| MESH:D011014 |
Pneumonia |
PMID:21983654 |
| MESH:D011015 |
Pneumonia, Aspiration |
PMID:17594875 |
| MESH:D011041 |
Poisoning |
PMID:22157354; PMID:23649840 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
PMID:24844129; PMID:25845602; PMID:27020608; PMID:36758786 |
| MESH:D011349 |
Proctitis |
PMID:12780922 |
| MESH:D011537 |
Pruritus |
PMID:28005965 |
| MESH:D011658 |
Pulmonary Fibrosis |
PMID:29758289 |
| MESH:D012130 |
Respiratory Hypersensitivity |
PMID:15003329; PMID:29758289 |
| MESH:D012141 |
Respiratory Tract Infections |
PMID:21810553 |
| MESH:D012595 |
Scleroderma, Systemic |
PMID:14979077 |
| MESH:D012912 |
Sneezing |
PMID:27545873 |
| MESH:D013274 |
Stomach Neoplasms |
PMID:12562630 |
| MESH:D013736 |
Testicular Neoplasms |
PMID:12562630 |
| MESH:D014456 |
Ulcer |
PMID:14633228; PMID:20884683 |
| MESH:D014581 |
Urticaria |
PMID:12371530; PMID:15628056; PMID:17680969 |
| MESH:D015352 |
Dry Eye Syndromes |
PMID:29860525 |
| MESH:D015431 |
Weight Loss |
PMID:14633228 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
PMID:12562630 |
| MESH:D016535 |
Bronchial Hyperreactivity |
PMID:14656365; PMID:16463957 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
PMID:12081698; PMID:12121405; PMID:12575846; PMID:12694215; PMID:12956347; PMID:14996049; PMID:15059100; PMID:15803868; PMID:15932584; PMID:16958921; PMID:17303043; PMID:17408435; PMID:17498414; PMID:18413101; PMID:18627677; PMID:18976378; PMID:20573164; PMID:20597931; PMID:20814622; PMID:26795242 |
| MESH:D017453 |
Dermatitis, Irritant |
PMID:17408435 |
| MESH:D018242 |
Neuroectodermal Tumors, Primitive |
PMID:26505805 |
| MESH:D018256 |
Adenomatous Polyps |
PMID:12562630 |
| MESH:D018366 |
Vasculitis, Leukocytoclastic, Cutaneous |
PMID:17680969 |
| MESH:D018450 |
Disease Progression |
PMID:24060340 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
PMID:36758786 |
| MESH:D020258 |
Neurotoxicity Syndromes |
PMID:15648056; PMID:16397905 |
| MESH:D053627 |
Asthenozoospermia |
PMID:16909603 |
| MESH:D054537 |
Atrioventricular Block |
PMID:4028383 |
| MESH:D056486 |
Chemical and Drug Induced Liver Injury |
PMID:17283889; PMID:20207655 |
| MESH:D059226 |
Nociceptive Pain |
PMID:21702498; PMID:23724298; PMID:23747933; PMID:27899695; PMID:28606623; PMID:30053451; PMID:31857126; PMID:33259823 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.